Novo Nordisk Q3 Earnings & Revenues Miss, GLP-1 Drugs Face US Hurdles
Post Content
Medicare Expands GLP-1 Coverage as MENU ORDER AI Prepares App Store Debut for the High-Protein / GLP-1 Dining Revolution
As the only health-tech app designed specifically for GLP-1 users who dine out — and for restaurants eager to welcome them back — MENU ORDER AI combines AI-powered menu scanning with real-time nutrition intelligence to help millions “Eat anywhere. Order smarter.” BOSTON, Nov. 6, 2025…
What doctors have to say about Trump’s announcement to reduce weight loss drug costs
President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday that would lower the cost of obesity drug prices for some patients on Medicare, Medicaid and the planned “TrumpRx” pharmaceutical website. Doctors spoke with CBS News about the deal. #glp1 #weightloss #trump CBS News 24/7 is the premier anchored streaming news service […]
Employers weigh rising GLP-1 cost pressures
Post Content
Man Faints in Oval Office as Trump Admin Announces Price Cuts in Weight-Loss Drugs
A man fainted in the Oval Office on Nov. 6 as the Trump administration announced sweeping price cuts to popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, starting in early 2026. Eli Lilly CEO David A. Ricks was speaking about the deal when an unidentified man behind him, wearing a black suit, white […]
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
WOBURN, MA, November 7, 2025 – Neurogastrx, Inc., today presented proof-of-concept data from its placebo-controlled Phase 2 clinical study of NG101 (metopimazine mesylate), an oral, peripherally restricted dopamine D2 receptor antagonist for…
Trump admin brings international drug pricing to Medicaid
Presented by the Coalition to Strengthen America’s Healthcare — State Medicaid programs that choose to participate in the model will be able to purchase drugs included in the pilot at prices aligned with those paid in select other countries. {beacon} Health Care The Big Story Trump admin brings international drug pricing to Medicaid A new payment model from the Centers for […]
Trump announces deal to lower cost of weight loss drug
President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and Zepbound to announce new costs for Medicare recipients and price reductions set to come in 2026. NBC News’ Liz Kreutz reports. For more context and news coverage of the most important stories of our day, click […]
Doctor discusses who could benefit from Trump’s deal on weight loss drugs
At the White House, President Trump announced a deal to make weight loss drugs more affordable. Mr. Trump says drug makers Eli Lilly and Novo Nordisk agreed to lower the price of their popular GLP-1 drugs. CBS News medical contributor Dr. Céline Gounder explains who might see those lower prices.
STAT+: Trump is making obesity drugs cheaper under Medicare. A landmark Biden policy might have helped
The Trump administration’s deal on weight loss drugs might have been made possible in part by Biden’s Medicare drug price negotiation program, three experts said. Trump’s deal will offer lower prices for weight loss drugs to Medicare and Medicaid users, along with patients paying out of pocket. Many of the program’s details were not included […]